BEVICRA 100MG

Bevicra 100mg Injection is an anticancer medication that contains the active ingredient Bevacizumab. This treatment is designed to inhibit tumor growth. It is prescribed in conjunction with other chemotherapy drugs for the management of metastatic breast cancer, brain cancer, cervical cancer, kidney cancer, lung cancer, and colorectal cancer. Additionally, it is utilized for treating ovarian cancer, fallopian tube cancer, or primary peritoneal cancer. Effective birth control should be employed during treatment and for at least six months following the final dose. Bevicra 100mg Injection is not advised for adolescents and children under 18 years of age. If you are considering pregnancy soon, consult your doctor regarding the preservation of ovaries, as this medication may lead to fertility issues in women. It is also recommended to refrain from breastfeeding, as this drug may affect the growth and development of your baby.

Bevicra 100mg Injection is frequently given in combination with other chemotherapy agents. Common side effects include constipation, loss of appetite, runny nose, fever, skin issues, and weight loss. Prior to commencing treatment with this medication, inform your doctor if you have high blood pressure, elevated blood sugar, gastrointestinal disorders, or heart conditions. This medication should not be taken for 28 days before and after any surgical procedures due to its association with poor wound healing and increased bleeding risks. It is important to notify your doctor of any dental problems that may require surgery before starting this medication. Should you experience any changes in vision or confusion, contact your doctor immediately to avoid complications.